(Stroke. 2000;31:383.)
© 2000 American Heart Association, Inc.
Original Contributions |
Effect of Hypervolemic Therapy on Cerebral Blood Flow After Subarachnoid Hemorrhage
A Randomized Controlled Trial
From the Departments of Neurology (L.L., S.A.M., M.E.F., L.M.K., E.C.R.) and Neurosurgery (R.A.S., A.B.), Neurological Institute, College of Physicians and Surgeons, and the Department of Biostatistics (M.C.P., H.Z., Y.C.W.), School of Public Health, Columbia University, New York, NY.
Correspondence to Stephan A. Mayer, MD, Division of Critical Care Neurology, Neurological Institute, 710 West 168th Street, Unit 39, New York, NY 10032. E-mail ras5{at}columbia.edu
Background and Purpose—Cerebral blood flow (CBF) is reduced after subarachnoid hemorrhage (SAH), and symptomatic vasospasm is a major cause of morbidity and mortality. Volume expansion has been reported to increase CBF after SAH, but CBF values in hypervolemic (HV) and normovolemic (NV) subjects have never been directly compared.
Methods—On the day after aneurysm clipping, we randomly assigned 82 patients to receive HV or NV fluid management until SAH day 14. In addition to 80 mL/h of isotonic crystalloid, 250 mL of 5% albumin solution was given every 2 hours to maintain normal (NV group, n=41) or elevated (HV group, n=41) cardiac filling pressures. CBF (133xenon clearance) was measured before randomization and approximately every 3 days thereafter (mean, 4.5 studies per patient).
Results—HV patients received significantly more fluid and had higher pulmonary artery diastolic and central venous pressures than NV patients, but there was no effect on net fluid balance or on blood volume measured on the third postoperative day. There was no difference in mean global CBF during the treatment period between HV and NV patients (P=0.55, random-effects model). Symptomatic vasospasm occurred in 20% of patients in each group and was associated with reduced minimum regional CBF values (P=0.04). However, there was also no difference in minimum regional CBF between the 2 treatment groups.
Conclusions—HV therapy resulted in increased cardiac filling pressures and fluid intake but did not increase CBF or blood volume compared with NV therapy. Although careful fluid management to avoid hypovolemia may reduce the risk of delayed cerebral ischemia after SAH, prophylactic HV therapy is unlikely to confer an additional benefit.
Key Words: blood volume • cerebral blood flow • cerebral vasospasm • subarachnoid hemorrhage
This article has been cited by other articles:
 |
|
 |
|
  R. Hoff, G. Rinkel, B. Verweij, A. Algra, and C. Kalkman Blood Volume Measurement to Guide Fluid Therapy After Aneurysmal Subarachnoid Hemorrhage: A Prospective Controlled Study Stroke, July 1, 2009; 40(7): 2575 - 2577. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Mutoh, K. Kazumata, T. Ishikawa, and S. Terasaka Performance of Bedside Transpulmonary Thermodilution Monitoring for Goal-Directed Hemodynamic Management After Subarachnoid Hemorrhage * Supplemental Data Stroke, July 1, 2009; 40(7): 2368 - 2374. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Bederson, E. S. Connolly Jr, H. H. Batjer, R. G. Dacey, J. E. Dion, M. N. Diringer, J. E. Duldner Jr, R. E. Harbaugh, A. B. Patel, and R. H. Rosenwasser Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association Stroke, March 1, 2009; 40(3): 994 - 1025. [Full Text] [PDF]
|
|
|
|
|
|
T. Mutoh, K. Kazumata, M. Ajiki, S. Ushikoshi, and S. Terasaka Goal-Directed Fluid Management by Bedside Transpulmonary Hemodynamic Monitoring After Subarachnoid Hemorrhage * Supplemental Material Stroke, December 1, 2007; 38(12): 3218 - 3224. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Blissitt, P. H. Mitchell, D. W. Newell, S. L. Woods, and B. Belza Cerebrovascular Dynamics With Head-of-Bed Elevation in Patients With Mild or Moderate Vasospasm After Aneurysmal Subarachnoid Hemorrhage Am. J. Crit. Care., March 1, 2006; 15(2): 206 - 216. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Firat, V. Gelebek, H. S. Orer, D. Belen, A. K. Firat, and F. Balkanci Selective Intraarterial Nimodipine Treatment in an Experimental Subarachnoid Hemorrhage Model AJNR Am. J. Neuroradiol., June 1, 2005; 26(6): 1357 - 1362. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Evidence-based Colloid Use in the Critically Ill: American Thoracic Society Consensus Statement Am. J. Respir. Crit. Care Med., December 1, 2004; 170(11): 1247 - 1259. [Full Text] [PDF]
|
|
|
|
|
|
H. Kasuya, H. Onda, T. Yoneyama, T. Sasaki, and T. Hori Bedside Monitoring of Circulating Blood Volume After Subarachnoid Hemorrhage Stroke, April 1, 2003; 34(4): 956 - 960. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Treggiari, J.-A. Romand, J.-B. Martin, A. Reverdin, D. A. Rufenacht, N. de Tribolet, A. L. Day, and P. V. Theodosopoulos Cervical Sympathetic Block to Reverse Delayed Ischemic Neurological Deficits After Aneurysmal Subarachnoid Hemorrhage * Sympathetic Block for Vasospasm Stroke, April 1, 2003; 34(4): 961 - 967. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Lagares, P.A. Gomez, J.F. Alen, R.D. Lobato, J. Campollo, J. Claassen, and S. A. Mayer Global Cerebral Edema After Subarachnoid Hemorrhage * Response Stroke, September 1, 2002; 33(9): 2153 - 2154. [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Wilkes and R. J. Navickis Patient Survival after Human Albumin Administration: A Meta-Analysis of Randomized, Controlled Trials Ann Intern Med, August 7, 2001; 135(3): 149 - 164. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. van Gijn and G. J. E. Rinkel Subarachnoid haemorrhage: diagnosis, causes and management Brain, February 1, 2001; 124(2): 249 - 278. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Belayev, Y. Liu, W. Zhao, R. Busto, and M. D. Ginsberg Human Albumin Therapy of Acute Ischemic Stroke : Marked Neuroprotective Efficacy at Moderate Doses and With a Broad Therapeutic Window Stroke, February 1, 2001; 32(2): 553 - 560. [Abstract] [Full Text] [PDF]
|
|